Impact of NSAID Use on Bleeding Rates for Patients Taking Rivaroxaban or ApixabanDecember 20, 2024Hematology
Skin Cancer Risk Elevated Among Blood, Marrow Transplant SurvivorsDecember 19, 2024MelanomaHematologyOncologyMixed Topics
How Are Patients Managing Intermediate-Risk Prostate Cancer?December 12, 2024Genitourinary CancerOncology
New Cancer Drugs: Do Patients Prefer Faster Access or Clinical Benefit?December 12, 2024Mixed TopicsBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell Disorders
Intratumoral Dendritic Cell Therapy Shows Promise in Early-Stage ERBB2-Positive Breast CancerDecember 9, 2024Breast Cancer
New Cancer Vaccines on the Horizon: Renewed Hope or Hype?December 6, 2024Mixed TopicsOncologyGenitourinary CancerMelanomaLymphoma & Plasma Cell DisordersLung Cancer
Inside the Patient-Oncologist Bond: Why It’s Often So StrongDecember 2, 2024Breast CancerMixed TopicsGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell Disorders
NCCN Expands Cancer Genetic Risk Assessment GuidelinesNovember 22, 2024Breast CancerGenitourinary CancerMixed TopicsOncology
